Dana-Farber study finds new approach to graft-versus-host disease treatment results in sustained improvement for some patients:

Dana-Farber study finds new approach to graft-versus-host disease treatment results in sustained improvement for some patients:   NCI Cancer Center News Scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients… The phase … Continue reading “Dana-Farber study finds new approach to graft-versus-host disease treatment results in sustained improvement for some patients:”

Dana-Farber study finds new approach to graft-versus-host disease treatment results in sustained improvement for some patients:

 

NCI Cancer Center News

Scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients… The phase I study, published in the Dec. 1 issue of the New England Journal of Medicine, involved allogeneic (donor) stem cell transplant patients with chronic graft-versus-host disease (GVHD), a multi-system inflammatory condition that arises when donor immune system cells launch an attack on a patient’s own tissues, leading to varied symptoms such as skin rash and thickened or scarred skin, lung inflammation, or hepatitis, among others.

Click here to read full press release from Dana-Farber Cancer Institute.

###

Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply